Dublin, Feb. 06, 2017 -- Research and Markets has announced the addition of the "Global Organ Preservation Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
The Global Organ Preservation Market is poised to grow at a CAGR of around 8.6% over the next decade to reach approximately $335.8 million by 2025. Some of the prominent trends that the market is witnessing include increasing compensation treatment for organ transplantation procedures, technical advancements and increasing elderly population, rising multi-organ breakdown cases in aging inhabitants, growth opportunities/investment opportunities.
Based on technique the market is categorized into hypothermic machine perfusion, static cold storage (SCS) technique, normothermic machine perfusion and other techniques. As per organ type the market is segmented into liver, lung, kidneys, heart, and other organs. Other organs are further segmented into pancreas and intestine.
By solution, the market is categorized into custodiol htk - (histidine-tryptophan-ketoglutarate) solution, human biosystem (hbs) solution, hypothermosol, lifor, perfadex, renograf, sirna transplant solution, university of wisconsin solution (uw solution), viaspan and other preservation solutions.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
Report Highlights:
- The report provides a detailed analysis on current and future market trends to identify the investment opportunities;
- Market forecasts till 2025, using estimated market values as the base numbers;
- Key market trends across the business segments, Regions and Countries;
- Key developments and strategies observed in the market;
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends;
- In-depth company profiles of key players and upcoming prominent players;
- Growth prospects among the emerging nations through 2025;
- Market opportunities and recommendations for new investments.
Companies Mentioned:
- 21st Century Medicine Inc.
- Bridge to Life Limited
- Bristol-Myers Squibb
- Claris Lifesciences Limited
- Dr. Franz Kohler Chemie GmbH
- Essential Pharmaceuticals, LLC
- Lifeline Scientific, Inc. (Organ Recovery Systems, Inc.)
- Organox Limited
- Paragonix Technologies, Inc.
- Preservation Solutions, Inc.
- Teva Pharmaceutical Industries Ltd.
- ToleroTech, Inc.
- Transmedics, Inc.
- Waters Medical Systems LLC [Institut Georges Lopez (IGL]
- Xvivo Perfusion AB
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
4 Organ Preservation Market, By Technique
5 Organ Preservation Market, By Organ Type
6 Organ Preservation Market, By Solution
7 Organ Preservation Market, By Geography
8 Key Player Activities
9 Leading Companies
For more information about this report visit http://www.researchandmarkets.com/research/63glxw/global_organ
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Blood Banking


OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Anta Sports Expands Global Footprint With Strategic Puma Stake
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO 



